SIC 2835 – In Vitro and In Vivo Diagnostic Substances
| Valuation | |
|---|---|
| Market Cap ($M) | 110.74 |
| Enterprise Value ($M) | 111.01 |
| Book Value ($M) | 31.38 |
| Book Value / Share | 0.91 |
| Price / Book | 3.53 |
| NCAV ($M) | 28.99 |
| NCAV / Share | 0.84 |
| Price / NCAV | 3.82 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.80 |
| Return on Assets (ROA) | -1.70 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.78 |
| Current Ratio | 6.78 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 45.53 |
| Assets | 47.92 |
| Liabilities | 16.54 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 5.65 | 0.00 | |
| 13G/A | Franklin Resources Inc | |||
| 13G | BlackRock, Inc. | 6.00 | ||
| 13G/A | Contrarian Alpha, LP | 6.60 | 9.77 | |
| 13G | Propel Bio Management, LLC | 6.81 | ||
| 13G | Callahan Patrick J. III | 9.90 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 25,729 | 134,193 | 19.17 | |
| 29,445 | 99,144 | 29.70 | |
| 37,062 | 218,169 | 16.99 | |
| 22,648 | 80,203 | 28.24 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABEO – Abeona Therapeutics Inc. | ABVC – ABVC BioPharma, Inc. |
| ACB – Aurora Cannabis Inc. | ACXP – Acurx Pharmaceuticals, Inc. |
| ADIL – Adial Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io